Black Book Market Research’s directional read of an 88-investor sample indicates that venture capital, private equity and investment banking participants are prioritizing investments in “AI That Ships” solutions, targeting proof thresholds such as unit economics (minimum 20% gross margin), established reimbursement pathways and demonstrable clinical outcomes. The flash poll shows renewed appetite for carve-outs—62% of respondents would consider asset sales with milestone bridges—and structured financings, with 48% expressing interest in milestone-linked debt. Special-situations capital has reemerged as a focus, with 54% of participants open to funding differentiated metabolic assets, provided the assets demonstrate at least 30% year-over-year revenue growth during pilot studies. These trends set a deliberate stage for deal activity during JPM Week (Jan. 12–15, 2026).

As the largest U.S. bank by assets, JPMorgan Chase’s upcoming quarterly results serve as the unofficial kickoff to earnings season and are closely watched for insights into loan growth, net interest income and trading revenue. Analysts expect that a 5% expansion in corporate lending and a 7% rise in trading revenue would signal resilient activity in capital markets despite current monetary policy. A key metric will be the net interest margin—consistent performance near 2.3% would suggest that rate-sensitive lending remains profitable. Investors will also scrutinize JPMorgan’s provision for credit losses: a normalized range of $2.5 billion to $3 billion would imply stable asset quality. The bank’s performance in wealth management, which has grown fee revenue by 9% year-to-date, will further inform sentiment across both regional and global financial services names.